Vimarsana
Biggest News Aggregation in the World

Page 22 - Exact Sciences Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exact Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exact Sciences Corp Today - Breaking & Trending Today

The Global Liquid Biopsy Market is Predicted to Reach US$ 9.53 Billion by 2028 - Vimarsana News

The Global Liquid Biopsy Market is Predicted to Reach US$ 9.53 Billion by 2028

/PRNewswire/ -- The "Global Liquid Biopsy Market by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type,...

New Cologuard® Modeling Data Show Patient Navigation Matters When Reaching Underserved Populations for Colorectal Cancer (CRC) Screening - Vimarsana News

New Cologuard® Modeling Data Show Patient Navigation Matters When Reaching Underserved Populations for Colorectal Cancer (CRC) Screening

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today shared data from modeling analyses that demonstrate Cologuard (mt-sDNA), with its included patient...

New Cologuard® Modeling Data Show Patient Navigation Matters When Reaching Underserved Populations for Colorectal Cancer (CRC) Screening - Vimarsana News

New Cologuard® Modeling Data Show Patient Navigation Matters When Reaching Underserved Populations for Colorectal Cancer (CRC) Screening

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today shared data from modeling analyses that demonstrate Cologuard (mt-sDNA), with its included patient...

Should I Avoid EXACT Sciences Corporation (EXAS)? - Vimarsana News

Should I Avoid EXACT Sciences Corporation (EXAS)?

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...

Exact Sciences receives regulatory approval for the Oncotype DX Breast Recurrence Score® Program in Japan - Vimarsana News

Exact Sciences receives regulatory approval for the Oncotype DX Breast Recurrence Score® Program in Japan

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that Japan's Ministry of Health, Labor and Welfare (MHLW) has approved the Oncotype DX...